Summary:
Study will evaluate the efficacy of a single, oral dose of study drug compared with placebo for the reduction of the transmission rate of influenza A or B.
Qualified Participants Must:
• Must be seen with 48 hours of the start of their influenza smyptoms.
•
Have not received a flu vaccine.
Qualified Participants May Receive:
Testing for influenza A and B and COVID.
Compensation for time and travel.